RHUMBLINE ADVISERS

Position in ONC — BeOne Medicines Ltd.

CIK 1115418 BOSTON, MA

Position in ONC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$229,115

-$40,830 QoQ

Shares Held

804

-11.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#201

of 282 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ONC ranks #230 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$229,115	804	-11.6%	Shares	Sole	2026-08-12
2026-03-31	$269,945	909	-0.5%	Shares	Sole	2026-05-12
2025-12-31	$277,682	914	-2.5%	Shares	Sole	2026-02-13
2025-09-30	$319,235	937	-17.5%	Shares	Sole	2025-11-06
2025-06-30	$274,991	1,136	-4.0%	Shares	Sole	2025-08-12
2025-03-31	$321,977	1,183	-39.4%	Shares	Sole	2025-05-29
2024-09-30	$438,019	1,951	0.0%	Shares	Sole	2024-11-12
2024-06-30	$278,349	1,951	-7.1%	Shares	Sole	2024-08-01
2024-03-31	$328,575	2,101	-29.3%	Shares	Sole	2024-05-09
2023-12-31	$535,669	2,970	-26.3%	Shares	Sole	2024-02-08
2023-09-30	$725,235	4,032	-14.1%	Shares	Sole	2023-11-09
2023-06-30	$837,118	4,695	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.